Hereditary diseases affecting the skeleton are heterogeneous in etiology and severity. Though many of these conditions are individually rare, the total number of people affected is great. These disorders often include dental-oral-craniofacial (DOC) manifestations, but the combination of the rarity and lack of in-depth reporting often limit our understanding and ability to diagnose and treat affected individuals. In this review, we focus on dental, oral, and craniofacial manifestations of rare bone diseases. Discussed are defects in 4 key physiologic processes in bone/tooth formation that serve as models for the understanding of other diseases in the skeleton and DOC complex: progenitor cell differentiation (fibrous dysplasia), extracellular matrix production (osteogenesis imperfecta), mineralization (familial tumoral calcinosis/hyperostosis hyperphosphatemia syndrome, hypophosphatemic rickets, and hypophosphatasia), and bone resorption (Gorham-Stout disease). For each condition, we highlight causative mutations (when known), etiopathology in the skeleton and DOC complex, and treatments. By understanding how these 4 foci are subverted to cause disease, we aim to improve the identification of genetic, molecular, and/or biologic causes, diagnoses, and treatment of these and other rare bone conditions that may share underlying mechanisms of disease.
AkintoyeSOLeeJSFeimsterTBooherSBrahimJKingmanA. (2003). Dental characteristics of fibrous dysplasia and McCune-Albright syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod96:275-282.
2.
AkintoyeSOBoyceAMCollinsMT (2013). Dental perspectives in fibrous dysplasia and McCune-Albright syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol116:e149-e155.
3.
Al-JamaliJGlaumRKassemAVossPJSchmelzeisenRSchonR (2012). Gorham-Stout syndrome of the facial bones: a review of pathogenesis and treatment modalities and report of a case with a rare cutaneous manifestations [sic]. Oral Surg Oral Med Oral Pathol Oral Radiol114:e23-e29.
4.
Benet-PagesAOrlikPStromTMLorenz-DepiereuxB (2005). An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet14:385-390.
5.
BerdalAMollaMDescroixV (2011). Vitamin D and oral health. In: Vitamin D. FeldmanDPikeJWAdamsJS, editors. San Diego, CA: Academic Press, pp. 521-532.
6.
BerksethKETebbenPJDrakeMTHefferanTEJewisonDEWermersRA (2013). Clinical spectrum of hypophosphatasia diagnosed in adults. Bone54:21-27.
ByersPHPyottSM (2012). Recessively inherited forms of osteogenesis imperfecta. Annu Rev Genet46:475-497.
9.
Chaussain-MillerCSindingCSeptierDWolikowMGoldbergMGarabedianM (2007). Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment. Oral Dis13:482-489.
10.
ChristouJJohnsonARHodgsonTA (2013). Bisphosphonate-related osteonecrosis of the jaws and its relevance to children—a review. Int J Paediatr Dent23:330-337.
11.
CollmannHMornetEGattenlöhnerSBeckCGirschickH (2009). Neurosurgical aspects of childhood hypophosphatasia. Childs Nerv Syst25:217-223.
12.
DevlinRDBoneHG3rdRoodmanGD (1996). Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab81:1893-1897.
13.
DumitrescuCEKellyMHKhosraviAHartTCBrahimJWhiteKE. (2009). A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features. Osteoporos Int20:1273-1278.
14.
FarrowEGImelEAWhiteKE (2011). Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and alphaKlotho). Best Pract Res Clin Rheumatol25:735-747.
15.
FosterBLNagatomoKJTsoHWTranABNocitiFHJrNarisawaS. (2012). Tooth root dentin mineralization defects in a mouse model of hypophosphatasia. J Bone Miner Res28:271-282.
16.
FosterBLNocitiFHJrSomermanMJ (2014). The rachitic tooth. Endocr Rev35:1-34.
17.
GalGMetzkerAGarlickJGoldYCalderonS (1994). Head and neck manifestations of tumoral calcinosis. Oral Surg Oral Med Oral Pathol77:158-166.
18.
GjørupHKjaerISonnesenLHaubekDBeck-NielsenSSHintzeH. (2011). Craniofacial morphology in patients with hypophosphatemic rickets: a cephalometric study focusing on differences between bone of cartilaginous and intramembranous origin. Am J Med Genet A 155A:2654-2660.
19.
GlassLRDagiTFDagiLR (2011). Papilledema in the setting of x-linked hypophosphatemic rickets with craniosynostosis. Case Rep Ophthalmol2:376-381.
20.
GorhamLWStoutAP (1955). Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 37A:985-1004.
21.
HartESKellyMHBrillanteBChenCCZiranNLeeJS. (2007). Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome. J Bone Miner Res22:1468-1474.
22.
HeydenGKindblomLGNielsenJM (1977). Disappearing bone disease. A clinical and histological study. J Bone Joint Surg Am59:57-61.
23.
HirayamaTSabokbarAItonagaIWatt-SmithSAthanasouNA (2001). Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J Pathol195:624-630.
24.
IchikawaSImelEAKreiterMLYuXMackenzieDSSorensonAH. (2007). A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Musculoskelet Neuronal Interact7:318-319.
25.
KatoKJeanneauCTarpMABenet-PagesALorenz-DepiereuxBBennettEP. (2006). Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem281:18370-18377.
26.
KellyMHBrillanteBCollinsMT (2008). Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int19:57-63.
27.
KiranDNAnupamaA (2011). Vanishing bone disease: a review. J Oral Maxillofac Surg69:199-203.
28.
KrstevskaAGaleSBlairF (2012). Tumoral calcinosis: a dental literature review and case report. Dent Update39:416-418, 421.
29.
KuriyamaDKMcElligottSCGlaserDWThompsonKS (2010). Treatment of Gorham-Stout disease with zoledronic acid and interferon-alpha: a case report and literature review. J Pediatr Hematol Oncol32:579-584.
30.
KuznetsovSAChermanNRiminucciMCollinsMTRobeyPGBiancoP (2008). Age-dependent demise of GNAS-mutated skeletal stem cells and “normalization” of fibrous dysplasia of bone. J Bone Miner Res23:1731-1740.
31.
LammogliaJJMericqV (2009). Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer. Horm Res71:178-184.
32.
LeeJSFitzGibbonEButmanJADufresneCRKushnerHWeintroubS. (2002). Normal vision despite narrowing of the optic canal in fibrous dysplasia. N Engl J Med347:1670-1676.
33.
LowingKAströmEOscarssonKASöderhallSEliassonAC (2007). Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta. Acta Paediatr96:1180-1183.
34.
MajoranaABardelliniEBrunelliPCLacaitaMCazzollaAPFaviaG (2010). Dentinogenesis imperfecta in children with osteogenesis imperfecta: a clinical and ultrastructural study. Int J Paediatr Dent20:112-118.
35.
MariniJCForlinoACabralWABarnesAMSan AntonioJDMilgromS. (2007). Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat28:209-221.
36.
Martinez-GlezVValenciaMCaparros-MartinJAAglanMTemtamySTenorioJ. (2012). Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat33:343-350.
37.
MilanoMWrightTLoechnerKJ (2011). Dental implications of osteogenesis imperfecta: treatment with IV bisphosphonate: report of a case. Pediatr Dent33:349-352.
38.
MillánJNarisawaSLemireILoiselTBoileauGLeonardP. (2008). Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res23:777-787.
39.
MollerGPriemelMAmlingMWernerMKuhlmeyASDellingG (1999). The Gorham-Stout syndrome (Gorham’s massive osteolysis). A report of six cases with histopathological findings. J Bone Joint Surg Br81:501-506.
MulpuriKJosephB (2000). Intramedullary rodding in osteogenesis imperfecta. J Pediatr Orthop20:267-273.
42.
MurthyAS (2009). X-linked hypophosphatemic rickets and craniosynostosis. J Craniofac Surg20:439-442.
43.
NicolaouNAgrawalYPadmanMFernandesJABellMJ (2012). Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonates. J Child Orthop6:21-27.
ReibelAManièreMClaussFDrozDAlembikYMornetE. (2009). Orodental phenotype and genotype findings in all subtypes of hypophosphatasia. Orphanet J Rare Dis4:6.
46.
ReinglasJRamphalRBromwichM (2011). The successful management of diffuse lymphangiomatosis using sirolimus: a case report. The Laryngoscope121:1851-1854.
47.
RiminucciMFisherLWShenkerASpiegelAMBiancoPGehron RobeyP (1997). Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol151:1587-1600.
48.
RiminucciMKuznetsovSAChermanNCorsiABiancoPGehron RobeyP (2003). Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone33:434-442.
49.
RodriguesTRGeorgettiAPMartinsLPereira NetoJSFosterBLNocitiFHJr (2012). Clinical correlate: case study of identical twins with cementum and periodontal defects resulting from odontohypophosphatasia. In: Mineralized tissues in oral and craniofacial science: biological principles and clinical correlates. McCauleyLKSomermanMJ, editors. Ames, IA: Wiley-Blackwell, pp 183-189.
50.
RuckJDahan-OlielNMontpetitKRauchFFassierF (2011). Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: functional outcomes at one year. J Child Orthop5:217-224.
51.
RuggieriPMontaltiMAngeliniAAlberghiniMMercuriM (2011). Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature. Skeletal Radiol40:1391-1397.
52.
SemlerOCheungMSGlorieuxFHRauchF (2010). Wormian bones in osteogenesis imperfecta: correlation to clinical findings and genotype. Am J Med Genet A152A:1681-1687.
53.
SillenceDOSennADanksDM (1979). Genetic heterogeneity in osteogenesis imperfecta. J Med Genet16:101-116.
54.
StantonRPIppolitoESpringfieldDLindamanLWeintroubSLeetA (2012). The surgical management of fibrous dysplasia of bone. Orphanet J Rare Dis7(Suppl 1):S1.
55.
TopazOShurmanDLBergmanRIndelmanMRatajczakPMizrachiM. (2004). Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet36:579-581.
56.
UrakawaIYamazakiYShimadaTIijimaKHasegawaHOkawaK. (2006). Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature444:770-774.
57.
van DijkFSCobbenJMKariminejadAMaugeriANikkelsPGvan RijnRR. (2011). Osteogenesis imperfecta: a review with clinical examples. Mol Syndromol2:1-20.
58.
WeinsteinLSShenkerAGejmanPVMerinoMJFriedmanESpiegelAM (1991). Activating mutations of the stimulatory G protein in the McCune-Albright syndrome [see comments]. N Engl J Med325:1688-1695.
59.
WhyteM (1994). Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev15:439-461.
60.
WhyteMPGreenbergCRSalmanNJBoberMBMcAlisterWHWenkertD. (2012). Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med366:904-913.
61.
YamaguchiTSugimotoTImaiYFukaseMFujitaTChiharaK (1995). Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide. Bone16(4 Suppl):247S-250S.
62.
YoungJWGalbraithMCunninghamJRoofBSVujicIGobienRP. (1983). Progressive vertebral collapse in diffuse angiomatosis. Metab Bone Dis Relat Res5:53-60.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
